Frank Sciurba, M.D., FCCP

No bio available.

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    COPD Foundation
    Date added:
    02/03/2026
    Date updated:
    02/03/2026
  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    Sanofi/Regeneron
    Date added:
    02/03/2026
    Date updated:
    02/03/2026
  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    AstraZeneca
    Date added:
    02/03/2026
    Date updated:
    02/03/2026
  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    GlaxoSmithKline (GSK)
    Date added:
    02/03/2026
    Date updated:
    02/03/2026
  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    Genentech
    Date added:
    02/03/2026
    Date updated:
    02/03/2026
  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    United Therapeutics
    Date added:
    02/03/2026
    Date updated:
    02/03/2026
  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    Uniquity
    Date added:
    02/03/2026
    Date updated:
    02/03/2026

Pages

Return to March 13, 2026 32nd Advances in Pulmonary and Critical Care Medicine - Hybrid Conference